导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 4.30% | 404/1050 |
| 近一周 | -2.18% | 482/1104 |
| 近一月 | -3.67% | 437/1102 |
| 近一季 | -9.03% | 623/1092 |
| 近半年 | -2.29% | 482/1070 |
| 近一年 | 8.41% | 379/1018 |
| 近两年 | 55.72% | 459/926 |
| 近三年 | 52.62% | 238/834 |
| 成立以来 | 80.32% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.19% 411/1070 |
17.35% 420/1101 |
- - |
- - |
| 2025 | 26.09% 564/1065 |
-0.47% 826/1014 |
3.26% 417/1038 |
21.26% 570/1050 |
1.17% 376/1065 |
| 2024 | 10.26% 282/1011 |
0.89% 269/960 |
-1.17% 386/983 |
14.04% 301/991 |
-3.03% 540/1011 |
| 2023 | -7.14% 257/952 |
5.49% 293/880 |
-1.97% 298/895 |
-12.30% 693/915 |
2.39% 59/952 |
| 2022 | -30.00% 631/867 |
-23.10% 671/773 |
19.79% 24/806 |
-16.57% 652/845 |
-8.91% 760/867 |
| 2021 | 24.87% 113/740 |
-1.95% 222/580 |
14.63% 242/659 |
3.43% 157/704 |
7.41% 136/740 |
| 2020 | 42.67% 283/554 |
-9.69% 378/419 |
13.54% 371/466 |
10.06% 251/517 |
26.43% 56/554 |
| 2019 | - - |
- - |
- - |
- - |
4.46% 354/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 鹏扬元合量化大盘C VS. 东吴新产业精选股票A(580008) |